%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Mikaela Smit, Rachel Cassidy, Alessandro Cozzi-Lepri, Eugenia Quiros-Roldan, Enrico Girardi, Alessia Mammone, Andrea Antinori, Annalisa Saracino, Francesca Bai, Stefano Rusconi, Giacomo Magnani, Francesco Castelli, Priscilla Hsue, Antonella d’Arminio Monforte, Timothy B. Hallett
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref008)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref009)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref009)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref009)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.ref009)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.g001)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0186638.s001)>>
endobj
25 0 obj
<>/Border[0 0 0]/A 26 0 R>>
endobj
26 0 obj
<>
endobj
13 0 obj
[27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
27 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 565.8197 m
199.9998 565.8197 l
199.9998 566.3197 l
575.9997 566.3197 l
f*
0.83 0.64 0.02 0 k
264.0189 469.3606 m
268.7811 469.3606 l
268.7811 469.3039 l
264.0189 469.3039 l
f*
475.9937 469.3606 m
480.6992 469.3606 l
480.6992 469.3039 l
475.9937 469.3039 l
f*
332.8441 443.3386 m
337.6063 443.3386 l
h
f*
240.0945 391.3512 m
244.8567 391.3512 l
h
f*
250.0157 391.3512 m
254.778 391.3512 l
h
f*
356.8819 365.3291 m
361.6441 365.3291 l
h
f*
395.6598 300.3591 m
400.422 300.3591 l
h
f*
237.5433 235.3323 m
242.3055 235.3323 l
h
f*
445.0394 120.926 m
449.8016 120.926 l
h
f*
457.6252 120.926 m
477.2409 120.926 l
h
f*
474.1795 107.9433 m
500.5417 107.9433 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(USA)Tj
2.2617 0 Td
(diagnosed)Tj
4.7741 0 Td
(with)Tj
/F10 1 Tf
0 Tc
1.9753 0 Td
()Tj
/F0 1 Tf
-0.0042 Tc
(1)Tj
1.5397 0 Td
(NCD)Tj
2.3691 0 Td
(is)Tj
0.931 0 Td
(estimated)Tj
4.5115 0 Td
(to)Tj
1.0444 0 Td
(increase)Tj
3.9506 0 Td
(from)Tj
2.208 0 Td
(64%)Tj
2.2021 0 Td
(and)Tj
1.8619 0 Td
(71%)Tj
2.202 0 Td
(in)Tj
0.9847 0 Td
(2015)Tj
2.4169 0 Td
(to)Tj
1.0443 0 Td
(89%)Tj
-36.2773 -1.474 Td
(and)Tj
1.8619 0 Td
(89%)Tj
2.202 0 Td
(by)Tj
1.2652 0 Td
(2035,)Tj
2.6914 0 Td
(respectivel)Tj
4.7264 0 Td
(y,)Tj
0.9906 0 Td
(driven)Tj
2.9062 0 Td
(by)Tj
1.2652 0 Td
(moderate)Tj
4.4041 0 Td
(cardiovascular)Tj
6.5883 0 Td
(disease)Tj
3.6224 0 Td
(\(CVD\))Tj
2.9719 0 Td
(\(hyper-)Tj
-35.4956 -1.474 Td
(tension)Tj
3.4015 0 Td
(and)Tj
1.8679 0 Td
(dyslipidaemia\),)Tj
6.8031 0 Td
(diabetes)Tj
3.9506 0 Td
(and)Tj
1.8679 0 Td
(malignancies)Tj
5.9796 0 Td
(in)Tj
0.9846 0 Td
(both)Tj
2.1424 0 Td
(countries.)Tj
4.5056 0 Td
(NCD)Tj
2.3692 0 Td
(treatment)Tj
-33.8724 -1.474 Td
(costs)Tj
2.5362 0 Td
(as)Tj
1.2651 0 Td
(a)Tj
0.7699 0 Td
(proportion)Tj
4.6607 0 Td
(of)Tj
1.0444 0 Td
(total)Tj
2.0886 0 Td
(direct)Tj
2.6377 0 Td
(HIV)Tj
1.8739 0 Td
(costs)Tj
2.5362 0 Td
(will)Tj
1.5815 0 Td
(increase)Tj
3.9505 0 Td
(from)Tj
2.2081 0 Td
(11%)Tj
2.202 0 Td
(to)Tj
1.0444 0 Td
(23%)Tj
2.2021 0 Td
(in)Tj
0.9846 0 Td
(Italy)Tj
2.035 0 Td
(and)Tj
1.8619 0 Td
(from)Tj
-37.4828 -1.474 Td
(40%)Tj
2.196 0 Td
(to)Tj
1.0504 0 Td
(56%)Tj
2.1961 0 Td
(in)Tj
0.9846 0 Td
(the)Tj
1.5934 0 Td
(USA)Tj
2.2677 0 Td
(in)Tj
0.9787 0 Td
(20152035.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 624.3023 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 607.2944 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(HIV)Tj
1.8738 0 Td
(patient)Tj
3.1867 0 Td
(profile)Tj
2.9003 0 Td
(in)Tj
0.9847 0 Td
(Italy)Tj
2.0349 0 Td
(and)Tj
1.8679 0 Td
(the)Tj
1.5934 0 Td
(USA)Tj
2.2617 0 Td
(is)Tj
0.931 0 Td
(shifting)Tj
3.3478 0 Td
(to)Tj
1.0503 0 Td
(older)Tj
2.411 0 Td
(patients)Tj
3.676 0 Td
(diagnosed)Tj
4.7742 0 Td
(with)Tj
1.9753 0 Td
(multiple)Tj
-34.869 -1.474 Td
(co-morbidity.)Tj
5.8781 0 Td
(This)Tj
2.0946 0 Td
(will)Tj
1.5815 0 Td
(increase)Tj
3.9506 0 Td
(NCD)Tj
2.3691 0 Td
(treatment)Tj
4.4041 0 Td
(costs)Tj
2.5363 0 Td
(and)Tj
1.8679 0 Td
(require)Tj
3.2882 0 Td
(multi-disciplinary)Tj
7.5073 0 Td
(patient)Tj
-35.4777 -1.468 Td
(management.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 513.411 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 496.4031 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Recent)Tj
2.9593 0 Td
(efforts)Tj
2.7553 0 Td
(to)Tj
1.0261 0 Td
(improve)Tj
3.5773 0 Td
(HIV)Tj
2.0239 0 Td
(care)Tj
1.8709 0 Td
(cascades)Tj
3.6113 0 Td
(have)Tj
2.0579 0 Td
(highlighted)Tj
4.7622 0 Td
(engagement)Tj
5.074 0 Td
(levels)Tj
2.3754 0 Td
(in)Tj
1.0318 0 Td
(care)Tj
1.8765 0 Td
(glob-)Tj
-35.0019 -1.2982 Td
(ally)Tj
1.5987 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.474 0 Td
(challenges)Tj
4.32 0 Td
(with)Tj
1.9956 0 Td
(starting)Tj
3.2655 0 Td
(and)Tj
1.7291 0 Td
(maintaining)Tj
5.1193 0 Td
(HIV-positive)Tj
5.4652 0 Td
(people)Tj
2.8573 0 Td
(on)Tj
1.2756 0 Td
(antiretroviral)Tj
-30.8294 -1.2983 Td
(therapy)Tj
3.2484 0 Td
(\(ART\))Tj
2.812 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.6044 0 Td
(With)Tj
2.279 0 Td
(effective)Tj
3.5093 0 Td
(ART)Tj
2.1373 0 Td
(and)Tj
1.7291 0 Td
(extended)Tj
3.8608 0 Td
(life)Tj
1.44 0 Td
(expectancy)Tj
4.6374 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(])Tj
1.372 0 Td
(new)Tj
1.8765 0 Td
(challenges)Tj
4.32 0 Td
(are)Tj
-34.8262 -1.3039 Td
(arising)Tj
2.931 0 Td
(around)Tj
3.1407 0 Td
(the)Tj
1.4684 0 Td
(long-term)Tj
4.2462 0 Td
(management)Tj
5.4368 0 Td
(of)Tj
1.0148 0 Td
(patient)Tj
3.0104 0 Td
(relating)Tj
3.2712 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(increasing)Tj
4.3313 0 Td
(burden)Tj
3.1237 0 Td
(of)Tj
1.0148 0 Td
(non-)Tj
-35.4838 -1.2983 Td
(communicable)Tj
6.1681 0 Td
(diseases)Tj
3.3789 0 Td
(\(NCDs\))Tj
3.3959 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.5987 0 Td
(Although)Tj
4.0025 0 Td
(the)Tj
1.474 0 Td
(pathophysiological)Tj
7.7272 0 Td
(mechanisms)Tj
5.2044 0 Td
(of)Tj
1.0148 0 Td
(NCDs)Tj
2.7155 0 Td
(in)Tj
-36.68 -1.2982 Td
(the)Tj
1.4683 0 Td
(context)Tj
3.1861 0 Td
(of)Tj
1.0148 0 Td
(HIV)Tj
2.0183 0 Td
(are)Tj
1.4513 0 Td
(not)Tj
1.576 0 Td
(fully)Tj
1.9786 0 Td
(understood,)Tj
5.0457 0 Td
(it)Tj
0.788 0 Td
(likely)Tj
2.3527 0 Td
(involves)Tj
3.4809 0 Td
(complex)Tj
3.6227 0 Td
(interactions)Tj
4.9719 0 Td
(between)Tj
-32.9553 -1.3039 Td
(traditional)Tj
4.4163 0 Td
(risk)Tj
1.7178 0 Td
(factors,)Tj
3.1294 0 Td
(including)Tj
4.0422 0 Td
(smoking,)Tj
3.9061 0 Td
(diet,)Tj
1.9672 0 Td
(and)Tj
1.7292 0 Td
(exercise,)Tj
3.5999 0 Td
(and)Tj
1.7348 0 Td
(HIV-specific)Tj
5.3405 0 Td
(risk)Tj
1.7178 0 Td
(factors,)Tj
-33.3012 -1.2983 Td
(for)Tj
1.3832 0 Td
(example)Tj
3.549 0 Td
(long-term)Tj
4.2519 0 Td
(immune)Tj
3.6284 0 Td
(activation)Tj
4.1499 0 Td
(and)Tj
1.7291 0 Td
(inflammation)Tj
5.6976 0 Td
(and)Tj
1.7348 0 Td
(toxicity)Tj
3.1974 0 Td
(related)Tj
2.9481 0 Td
(to)Tj
1.0261 0 Td
(long-term)Tj
-33.2955 -1.2983 Td
(ART)Tj
2.1373 0 Td
(use)Tj
1.5307 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
-2.4718 -1.3039 Td
(A)Tj
0.907 0 Td
(recent)Tj
2.7099 0 Td
(model-based)Tj
5.3462 0 Td
(study)Tj
2.3867 0 Td
(provided)Tj
3.8211 0 Td
(the)Tj
1.4683 0 Td
(first)Tj
1.8029 0 Td
(insight)Tj
2.9593 0 Td
(into)Tj
1.8368 0 Td
(the)Tj
1.474 0 Td
(clinical)Tj
3.0728 0 Td
(implications)Tj
5.176 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
-35.172 -1.2983 Td
(ageing)Tj
2.8232 0 Td
(population)Tj
4.5921 0 Td
(in)Tj
1.0318 0 Td
(The)Tj
1.7859 0 Td
(Netherlands)Tj
5.1136 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
1.6044 0 Td
(It)Tj
0.8561 0 Td
(showed)Tj
3.2541 0 Td
(that)Tj
1.7745 0 Td
(the)Tj
1.474 0 Td
(mean)Tj
2.4435 0 Td
(age)Tj
1.542 0 Td
(of)Tj
1.0148 0 Td
(HIV-positive)Tj
-29.31 -1.2982 Td
(patients)Tj
3.3675 0 Td
(is)Tj
0.8447 0 Td
(expected)Tj
3.7247 0 Td
(to)Tj
1.0261 0 Td
(increase)Tj
3.4696 0 Td
(rapidly)Tj
3.0387 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(coming)Tj
3.2541 0 Td
(15)Tj
1.1679 0 Td
(years,)Tj
2.4945 0 Td
(accompanied)Tj
5.5445 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.652 0 Td
(sharp)Tj
-32.2694 -1.3039 Td
(increase)Tj
3.4695 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(burden)Tj
3.1295 0 Td
(of)Tj
1.0148 0 Td
(both)Tj
2.0579 0 Td
(NCDs)Tj
2.7156 0 Td
(and)Tj
1.7291 0 Td
(use)Tj
1.5364 0 Td
(of)Tj
1.0148 0 Td
(co-medication)Tj
6.0151 0 Td
(\(in)Tj
1.3776 0 Td
(addition)Tj
3.5943 0 Td
(to)Tj
1.0261 0 Td
(ART\).)Tj
2.7043 0 Td
(The)Tj
-33.8908 -1.2983 Td
(study)Tj
2.3867 0 Td
(highlighted)Tj
4.7679 0 Td
(the)Tj
1.4683 0 Td
(clinical)Tj
3.0727 0 Td
(implications)Tj
5.1761 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6781 0 Td
(disease)Tj
3.016 0 Td
(shift,)Tj
2.1883 0 Td
(estimating)Tj
4.405 0 Td
(that)Tj
1.7745 0 Td
(40%)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
-33.8908 -1.2983 Td
(will)Tj
1.661 0 Td
(likely)Tj
2.3585 0 Td
(experience)Tj
4.507 0 Td
(complications)Tj
5.8393 0 Td
(due)Tj
1.6952 0 Td
(to)Tj
1.0261 0 Td
(contra-indications)Tj
7.6025 0 Td
(or)Tj
1.0998 0 Td
(drug-interactions)Tj
7.2113 0 Td
(between)Tj
-33.0007 -1.2982 Td
(co-medication)Tj
6.015 0 Td
(and)Tj
1.7292 0 Td
(recommended)Tj
6.0377 0 Td
(ART)Tj
2.1373 0 Td
(by)Tj
1.1792 0 Td
(2030)Tj
2.126 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
1.5987 0 Td
(Having)Tj
3.1578 0 Td
(robust)Tj
2.7949 0 Td
(national)Tj
3.5036 0 Td
(projections)Tj
4.6999 0 Td
(for)Tj
-34.9793 -1.3039 Td
(the)Tj
1.4683 0 Td
(nature)Tj
2.8233 0 Td
(and)Tj
1.7291 0 Td
(scale)Tj
2.109 0 Td
(of)Tj
1.0148 0 Td
(NCD)Tj
2.3584 0 Td
(burden)Tj
3.1237 0 Td
(and)Tj
1.7292 0 Td
(likely)Tj
2.3527 0 Td
(economic)Tj
4.1442 0 Td
(implications)Tj
5.176 0 Td
(for)Tj
1.3833 0 Td
(HIV)Tj
2.024 0 Td
(care)Tj
1.8708 0 Td
(will)Tj
1.6668 0 Td
(help)Tj
-34.9736 -1.2983 Td
(inform)Tj
3.0217 0 Td
(national)Tj
3.5036 0 Td
(and)Tj
1.7291 0 Td
(regional)Tj
3.4809 0 Td
(guidelines)Tj
4.2803 0 Td
(regarding)Tj
4.0932 0 Td
(the)Tj
1.4683 0 Td
(screening,)Tj
4.2803 0 Td
(monitoring)Tj
4.8189 0 Td
(and)Tj
1.7291 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
-36.544 -1.2983 Td
(NCDs)Tj
2.7155 0 Td
(within)Tj
2.812 0 Td
(HIV)Tj
2.0239 0 Td
(care.)Tj
-6.3552 -1.3039 Td
(In)Tj
1.1111 0 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(we)Tj
1.3266 0 Td
(adapted)Tj
3.3845 0 Td
(an)Tj
1.2019 0 Td
(individual-based)Tj
6.8882 0 Td
(model)Tj
2.7439 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(ageing)Tj
2.8233 0 Td
(HIV-positive)Tj
5.4651 0 Td
(population)Tj
-32.6945 -1.2983 Td
(on)Tj
1.2755 0 Td
(ART)Tj
2.1373 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(])Tj
1.372 0 Td
(to)Tj
1.0261 0 Td
(Italy)Tj
1.9956 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(United)Tj
3.0217 0 Td
(States)Tj
2.5115 0 Td
(of)Tj
1.0148 0 Td
(America)Tj
3.6453 0 Td
(\(USA\))Tj
2.7949 0 Td
(by)Tj
1.1792 0 Td
(using)Tj
2.3925 0 Td
(real-world)Tj
4.3823 0 Td
(data)Tj
1.9105 0 Td
(to)Tj
1.0262 0 Td
(pro-)Tj
-34.8829 -1.2982 Td
(vide)Tj
1.8935 0 Td
(the)Tj
1.4683 0 Td
(first)Tj
1.8028 0 Td
(projections)Tj
4.7055 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(changing)Tj
3.9004 0 Td
(NCD)Tj
2.3527 0 Td
(burden)Tj
3.1295 0 Td
(and)Tj
1.7291 0 Td
(direct)Tj
2.5285 0 Td
(NCD)Tj
2.3584 0 Td
(treatment)Tj
4.1329 0 Td
(costs)Tj
2.1713 0 Td
(associ-)Tj
-34.6561 -1.3039 Td
(ated)Tj
1.9048 0 Td
(with)Tj
1.9956 0 Td
(treating)Tj
3.3279 0 Td
(these)Tj
2.2506 0 Td
(increasingly)Tj
5.0343 0 Td
(complex)Tj
3.6227 0 Td
(patients)Tj
3.3675 0 Td
(in)Tj
1.0318 0 Td
(those)Tj
2.3414 0 Td
(countries)Tj
3.9458 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(coming)Tj
3.2484 0 Td
(two)Tj
-34.5767 -1.2983 Td
(decades.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 170.022 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(Method)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Model)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 134.9858 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Two)Tj
2.0182 0 Td
(individual-based)Tj
6.8938 0 Td
(models)Tj
3.1068 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(ageing)Tj
2.8233 0 Td
(HIV-positive)Tj
5.4708 0 Td
(population)Tj
4.5865 0 Td
(were)Tj
2.1259 0 Td
(developed,)Tj
4.4957 0 Td
(one)Tj
-34.0041 -1.2982 Td
(for)Tj
1.3832 0 Td
(Italy)Tj
1.9956 0 Td
(and)Tj
1.7291 0 Td
(one)Tj
1.7008 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(USA,)Tj
2.3414 0 Td
(by)Tj
1.1792 0 Td
(adapting)Tj
3.7134 0 Td
(an)Tj
1.2019 0 Td
(existing)Tj
3.3165 0 Td
(model)Tj
2.7439 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
0.83 0.64 0.02 0 k
1.5987 0 Td
(Fig)Tj
1.4797 0 Td
(1)Tj
0 g
0.6973 0 Td
(illustrates)Tj
4.0536 0 Td
(the)Tj
1.4683 0 Td
(basic)Tj
-33.4599 -1.2983 Td
(model)Tj
2.7439 0 Td
(structure,)Tj
4.0478 0 Td
(with)Tj
1.9956 0 Td
(full)Tj
1.5307 0 Td
(details)Tj
2.7779 0 Td
(of)Tj
1.0148 0 Td
(model)Tj
2.7439 0 Td
(design)Tj
2.812 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(supplement)Tj
4.9039 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(S1)Tj
1.508 0 Td
(File)Tj
0 g
(\).)Tj
2.2507 0 Td
(Briefly,)Tj
3.0784 0 Td
(the)Tj
-33.9134 -1.3039 Td
(model)Tj
2.7439 0 Td
(followed)Tj
3.651 0 Td
(the)Tj
1.4683 0 Td
(ageing)Tj
2.8233 0 Td
(Italian)Tj
2.7893 0 Td
(and)Tj
1.7291 0 Td
(US)Tj
1.4286 0 Td
(HIV-positive)Tj
5.4709 0 Td
(population)Tj
4.5921 0 Td
(on)Tj
1.2756 0 Td
(ART)Tj
2.1373 0 Td
(from)Tj
2.2053 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 527.9244 100.4598 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(st)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 535.011 95.9811 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(January)Tj
-33.4996 -1.2982 Td
(2010)Tj
2.1203 0 Td
(to)Tj
1.0262 0 Td
(31)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 241.0015 87.4204 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(st)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 248.0881 82.9984 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(December)Tj
4.3483 0 Td
(2035,)Tj
2.3527 0 Td
(and)Tj
1.7291 0 Td
(probabilistically)Tj
6.5764 0 Td
(simulated)Tj
4.1215 0 Td
(clinical)Tj
3.0784 0 Td
(events)Tj
2.7269 0 Td
(\(hypertension,)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 404.6173 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Non-com)Tj
3.9897 0 Td
(municable)Tj
4.6914 0 Td
(disease)Tj
3.6071 0 Td
(and)Tj
1.8497 0 Td
(care)Tj
2.133 0 Td
(costs)Tj
2.5229 0 Td
(in)Tj
0.978 0 Td
(HIV)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01866)Tj
4.089 0 Td
(38)Tj
0 g
2.0906 0 Td
(October)Tj
3.7276 0 Td
(23,)Tj
1.5874 0 Td
(2017)Tj
33.5908 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(12)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Bristol-Me)Tj
3.848 0 Td
(yers)Tj
1.7929 0 Td
(Squibb,)Tj
3.0615 0 Td
(Gilead,)Tj
2.7283 0 Td
(ViiV)Tj
1.6583 0 Td
(Health)Tj
2.5725 0 Td
(Care,)Tj
-15.6615 -1.3748 Td
(Merck)Tj
2.5441 0 Td
(Sharp)Tj
2.4236 0 Td
(Dohme,)Tj
3.1536 0 Td
(ABBvie,)Tj
3.0543 0 Td
(Janssen.)Tj
3.5008 0 Td
(FB)Tj
1.1623 0 Td
(has)Tj
-15.8387 -1.3749 Td
(received)Tj
3.3023 0 Td
(travel)Tj
2.2394 0 Td
(grants)Tj
2.5725 0 Td
(from)Tj
2.0126 0 Td
(Bristol-My)Tj
3.8481 0 Td
(ers)Tj
1.3677 0 Td
(Squibb.)Tj
-15.3426 -1.3748 Td
(TBH)Tj
1.8071 0 Td
(reports)Tj
2.8771 0 Td
(grants)Tj
2.5725 0 Td
(from)Tj
2.0126 0 Td
(Gilead)Tj
2.5087 0 Td
(Sciences,)Tj
3.7418 0 Td
(during)Tj
-15.5198 -1.3748 Td
(the)Tj
1.3677 0 Td
(conduct)Tj
3.2173 0 Td
(of)Tj
0.9426 0 Td
(the)Tj
1.3748 0 Td
(study;)Tj
2.4874 0 Td
(grants)Tj
2.5724 0 Td
(from)Tj
2.0127 0 Td
(BMGF,)Tj
2.7283 0 Td
(World)Tj
-16.7032 -1.3748 Td
(Bank,)Tj
2.2889 0 Td
(UNAID)Tj
2.5371 0 Td
(S,)Tj
0.9708 0 Td
(Rush)Tj
2.1757 0 Td
(Foundation,)Tj
4.5779 0 Td
(Wellcome)Tj
3.9048 0 Td
(Trust,)Tj
-16.4552 -1.3748 Td
(personal)Tj
3.4016 0 Td
(fees)Tj
1.7433 0 Td
(from)Tj
2.0126 0 Td
(BMGF,)Tj
2.7284 0 Td
(New)Tj
1.8708 0 Td
(York)Tj
1.9489 0 Td
(Univers)Tj
2.8205 0 Td
(ity,)Tj
-16.5261 -1.3748 Td
(WHO,)Tj
2.4236 0 Td
(GFATM.)Tj
3.2103 0 Td
(ADAM)Tj
2.6078 0 Td
(reports)Tj
2.8843 0 Td
(personal)Tj
3.4016 0 Td
(fees)Tj
1.7363 0 Td
(from)Tj
-16.2639 -1.3748 Td
(Jannsen,)Tj
3.5504 0 Td
(Gilead)Tj
2.5087 0 Td
(Sciences,)Tj
3.7417 0 Td
(Merck)Tj
2.5512 0 Td
(Sharp)Tj
2.4166 0 Td
(Dohme,)Tj
-14.7686 -1.3748 Td
(Bristol-My)Tj
3.848 0 Td
(ers)Tj
1.3748 0 Td
(Squibb)Tj
2.8276 0 Td
(and)Tj
1.5945 0 Td
(Abbive)Tj
2.7284 0 Td
(and)Tj
1.5874 0 Td
(funds)Tj
2.3173 0 Td
(paid)Tj
1.7788 0 Td
(to)Tj
-18.0568 -1.3749 Td
(institution)Tj
3.8834 0 Td
(by)Tj
1.1127 0 Td
(Gilead)Tj
2.5086 0 Td
(Sciences.)Tj
3.7418 0 Td
(EG)Tj
1.2827 0 Td
(reports)Tj
2.8772 0 Td
(personal)Tj
-15.4064 -1.3748 Td
(fees)Tj
1.7362 0 Td
(from)Tj
2.0126 0 Td
(Janssen,)Tj
3.5008 0 Td
(Otsuka)Tj
2.7992 0 Td
(Novel)Tj
2.3174 0 Td
(Products,)Tj
3.7914 0 Td
(Gilead)Tj
-16.1576 -1.3748 Td
(Sciences,)Tj
3.7417 0 Td
(Angeletti)Tj
3.43 0 Td
(and)Tj
1.5945 0 Td
(funds)Tj
2.3173 0 Td
(paid)Tj
1.7788 0 Td
(to)Tj
0.9496 0 Td
(institution)Tj
-13.8119 -1.3748 Td
(from)Tj
2.0126 0 Td
(Gilead)Tj
2.5086 0 Td
(Sciences)Tj
3.515 0 Td
(and)Tj
1.5945 0 Td
(Janssen)Tj
3.0473 0 Td
(.)Tj
0.4465 0 Td
(AS)Tj
1.2685 0 Td
(received)Tj
-14.393 -1.3748 Td
(funds)Tj
2.3173 0 Td
(from)Tj
2.0126 0 Td
(ViiV,)Tj
1.878 0 Td
(Gilead)Tj
2.5087 0 Td
(MSD,)Tj
2.3102 0 Td
(Abbvie,)Tj
2.9551 0 Td
(Jansen,)Tj
-13.9819 -1.3748 Td
(BMS.)Tj
2.2464 0 Td
(PH)Tj
1.3323 0 Td
(has)Tj
1.5378 0 Td
(received)Tj
3.3024 0 Td
(consultanc)Tj
4.0252 0 Td
(y)Tj
0.6449 0 Td
(payments)Tj
3.8623 0 Td
(and)Tj
-16.9513 -1.3748 Td
(speaking)Tj
3.522 0 Td
(fees)Tj
1.7363 0 Td
(from)Tj
2.0126 0 Td
(Gilead)Tj
2.5087 0 Td
(and)Tj
1.5874 0 Td
(Pfizer.)Tj
2.5086 0 Td
(This)Tj
1.7788 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
-17.667 -1.3749 Td
(alter)Tj
1.8212 0 Td
(our)Tj
1.4741 0 Td
(adherenc)Tj
3.4086 0 Td
(e)Tj
0.6449 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3316 0 Td
(ONE)Tj
1.8637 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
-15.5056 -1.3819 Td
(sharing)Tj
2.9834 0 Td
(data)Tj
1.793 0 Td
(and)Tj
ET
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
BT
6.3638 59.3366 Td
(materials.)Tj
ET
Q
endstream
endobj
38 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 41 0 R/Contents 42 0 R/TrimBox[0 0 612 792]>>
endobj
40 0 obj
<>stream
x콿wOr8X8&Ȇsԁ=2l7#B 60I0r$ JV,
!!y#|u警s{>u.K>>ߟ @ @ @ @ @ @ @ @A#_ @ @ 6#[9; @ @ #L @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Lj @ @ ؟ s @ @ Nc! @ @ xf9 @ @ XN ;; `6C:G @ DtCM6C:@ @ DtsS 6C:G @ DtCM6C:@ @ DtsS 6C:G @ DtCM6C:@ @ DtsS 6C:G @ DtCM6Ý;Q1 @ tڧ~F:'O&!t2C @ @Rt2MB4 N"0ayR @ ٰЅh,r D`B'!@ @ '@'a5X8=NIC, @ 0NNfjB% p {̓
X @ @` ̆Մ.DcK@$:'@ @ 8:
]"I&!t2O*b @ qt2VE.! LCdT0@ @ d6&t!\B '<` @ lXMB4 N"0ayR @ ٰЅh,r D`B'!@ @ '@'a5X8=NIC, @ 0NNfjB% p {̓
X @ @` ̆Մ.DcK@$:'@ @ 8:
]"I&!t2O*b @ qt2VE.! LCdT0@ @ d6&t!\B '<` @ lXMB4 N"0ayR @ ٰЅh,r D`B'!@ @ '@'a5X8=NIC, @ 0NNfjB% p {̓
X @ @` ̆Մ.DcK@$:'@ @ 8:
]"I&!t2O*b @ qt2VE.! LCdT0@ @ d6&t!\B '<`!!FPrc*@ yk HNfsI h.!3!wN
h' D y!:G@M`xjG wfC.t!nxO!{Ga.C>rΩA'3c,<1N xI!0NN:䤙K/.!I
X!|KԠy*7BM:/؇ UO.
3/x&
Mw҇hمhLs 8vKf!KwN
:0Χ&d7HM'@UR!kc&M`Q{;a31 nI=d ΩA'3R# ,
$IPŞP!{$@a BNM3i.! nI=d ΩA'3sC*d-D¾ ,j#y'=,pfv!]bR-i,a95dX8y$%$ jT>*dϼ՛(7rCtIB sf1%R-雹,a95d^8 51ߟ UzHP7Ea:龜E:.ĠKL@
%M3%;K'$d78$AC'{zBz &@n;C4aB4@j%}3%;KSX&Z~
&=@HÙمtiHAciyԠbG$}PbOO=Wo!y'}&̙]4HMcoyԠz |jKvp~T9Z!?o"@a輓`83.1
)p4C0t2S,U